Rebecca Pharaon

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer”.

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

Journal of Clinical Medicine(2022)10.3390/jcm11051429

N/A

0.524DataRank · unranked

32 citations

Leonidas Arvanitis, Jeremy Fricke, Rebecca Pharaon, Angel Ray Baroz, Michelle Afkhami +4 more

Co-stimulatory and co-inhibitory Immune Markers in Solid Tumors With MET Alterations

Future Science OA(2020)10.2144/fsoa-2020-0159

N/A

0.165DataRank · unranked

2 citations

Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke +14 more

Rapid progression of disease from immunotherapy following targeted therapy: insights into treatment management and sequence

Journal of Thoracic Disease(2020)10.21037/jtd.2019.08.14

N/A

0DataRank · unranked

0 citations

Isa Mambetsariev, Jeremy Fricke, Ravi Salgia, Rebecca Pharaon

Precision medicine and actionable alterations in lung cancer: A single institution experience

PLoS ONE(2020)10.1371/journal.pone.0228188

N/A

0DataRank · unranked

9 citations

Yingyu Wang, Chen Chen, Sorena Nadaf, Rebecca Pharaon, Jeremy Fricke +19 more

Alterations in STK11 to limit response to immune checkpoint inhibitors in lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21503

N/A

0DataRank · unranked

0 citations

Isa Mambetsariev, Rebecca Pharaon, Angel Ray Baroz, Dan Zhao, Erminia Massarelli +3 more

Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer

CHEST Journal(2021)10.1016/j.chest.2021.04.016

N/A

0DataRank · unranked

44 citations

Isa Mambetsariev, Rebecca Pharaon, Jeremy Fricke, Hatim Husain, Karen L. Reckamp +5 more

Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.009

N/A

0DataRank · unranked

7 citations

Isa Mambetsariev, Rebecca Pharaon, Jeremy Fricke, Angel Ray Baroz, Hannah Romo +4 more

Evaluation of immune-related adverse events in patients treated with sequential immunotherapy and tyrosine kinase inhibitor treatment in non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21562

N/A

0DataRank · unranked

0 citations

Isa Mambetsariev, Jeremy Fricke, Rebecca Pharaon, Dan Zhao, Marianna Koczywas +3 more

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival

Journal of Thoracic Disease(2020)10.21037/jtd.2020.04.18

N/A

0DataRank · unranked

46 citations

Isa Mambetsariev, Rohan Gupta, Srisairam Achuthan, Yingyu Wang, Rebecca Pharaon +5 more